Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 04 - 02 entities : Abbvie inc. save search
AbbVie Announces Extension of Review for Supplemental New Drug Application of Upadacitinib for the Treatment of Moderate to Severe Atopic Dermatitis
Published: 2021-04-02 (Crawled : 22:00) - prnewswire.com
ABBV | News | $168.21 -0.78% 1.2M
|
Health Technology
| Email alert
Add to watchlist
new drug treatment dermatitis drug atopic dermatitis
Global Uveitis Drugs Market- AbbVie Inc., Alimera Sciences Inc., Amgen Inc., among others to contribute to the market growth|Industry Analysis, Market Trends, Market Growth, Opportunities and Forecast 2025
Published: 2021-04-02 (Crawled : 04:00) - prnewswire.com
AMGN | News | $274.15 0.22% 900K
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.755 0.49% 1.1M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $168.21 -0.78% 1.2M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $148.22 -0.9% 3.3M
|
Health Technology
| Email alert
Add to watchlist
BIIB | $199.91 3.48% 1.9M
|
Health Technology
| Email alert
Add to watchlist
drug growth
Selective Serotonin Reuptake Inhibitors (SSRIs) Market- AbbVie Inc., Apotex Inc., Aurobindo Pharma Ltd., among others to contribute to the market growth|Industry Analysis, Market Trends, Opportunities and Forecast 2025
Published: 2021-04-02 (Crawled : 03:00) - prnewswire.com
BHC | $8.49 -0.47% 380K
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $168.21 -0.78% 1.2M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.755 -1.18% 660K
|
Health Technology
| Email alert
Add to watchlist
growth
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.